Cargando…

Hematopoietic Stem Cells (HSC) and Granulocyte Macrophage Progenitors (GMP) are the Oxidative Stress Targets in Low/Intermediate-1 Risk Myelodysplastic Syndromes

INTRODUCTION: Myelodysplastic Syndromes (MDS) are a heterogenous group of clonal hematopoietic stem cell malignancies. Previous studies showed that Reactive Oxygen Species (ROS) play a role in the pathogenesis and clinical evolution of MDS, contributing to Hematopoietic Stem and Progenitor Cells (HS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giai, Valentina, Bensi, Thea, Bertassello, Claudia, Savio, Michela, Ferrero, Dario, Ciriello, Maria Matilde, Ladetto, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836226/ https://www.ncbi.nlm.nih.gov/pubmed/36644527 http://dx.doi.org/10.26502/jbb.2642-91280063

Ejemplares similares

Calcium Pyrophosphate Dihydrate Crystals Increase the Granulocyte/Monocyte Progenitor (GMP) and Enhance Granulocyte and Monocyte Differentiation In Vivo
por: Onai, Nobuyuki, et al.
Publicado: (2020)

Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation
por: Barone, Cristiana, et al.
Publicado: (2023)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
por: Luo, Bingqing, et al.
Publicado: (2022)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

Filgrastim-Associated Pneumonitis in Cancer Patient Undergoing Hematopoietic Stem Cell (HSC) Mobilization for Autologous-HSC Transplantation
por: Patel, Drashti R, et al.
Publicado: (2020)

Cobalt protoporphyrin IX increases endogenous G‐CSF and mobilizes HSC and granulocytes to the blood
por: Szade, Agata, et al.
Publicado: (2019)

HSC-Explorer: A Curated Database for Hematopoietic Stem Cells
por: Montrone, Corinna, et al.
Publicado: (2013)

Intermediate progenitor cells provide a transition between hematopoietic progenitors and their differentiated descendants
por: Spratford, Carrie M., et al.
Publicado: (2021)

Contributions of Embryonic HSC-Independent Hematopoiesis to Organogenesis and the Adult Hematopoietic System
por: Neo, Wen Hao, et al.
Publicado: (2021)

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
por: Ohmine, Seiga, et al.
Publicado: (2011)

Unsuspected gastric granulocytic sarcoma in a patient with myelodysplastic syndrome.
por: Jeon, H. J., et al.
Publicado: (1996)

Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region
por: Rybtsov, Stanislav, et al.
Publicado: (2011)

MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival
por: Huo, Yi, et al.
Publicado: (2018)

Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress
por: Seyfried, Allison N., et al.
Publicado: (2020)

A Case of Granulocytic Sarcoma of the Brain in a Patient with Myelodysplastic Syndrome
por: Lee, Ho Soo, et al.
Publicado: (1995)

Cutaneous granulocytic sarcoma and Koebner phenomenon in a context of myelodysplastic syndrome
por: Nizery-Guermeur, Constance, et al.
Publicado: (2015)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
por: Dimitriou, Marios, et al.
Publicado: (2016)

Granulocyte‐colony‐stimulating Factor Enhances the Circulating Hematopoietic Progenitors in Lung Cancer Patients Treated with Cisplatin‐containing Regimens
por: Mukai, Jun‐nosuke, et al.
Publicado: (1992)

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo
por: Knorr, Katherine L.B., et al.
Publicado: (2016)

Mobilization of hematopoietic progenitor cells with granulocyte colony stimulating factors for autologous transplant in hematologic malignancies: a single center experience
por: Gabús, Raul, et al.
Publicado: (2011)

Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute Myeloid Leukemia/Myelodysplastic Syndromes
por: Kassem, Neemat M., et al.
Publicado: (2017)

Quality of life aspects of a low protein diet using GMP in patients with phenylketonuria
por: Bensi, Giulia, et al.
Publicado: (2022)

Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures
por: Masala, Erico, et al.
Publicado: (2018)

High expression of PIM2 induces HSC proliferation in myelodysplastic syndromes via the IDH1/HIF1-α signaling pathway
por: Liu, Zhaoyun, et al.
Publicado: (2019)

Identification of a Siglec-F+ granulocyte-macrophage progenitor
por: Bolden, Jessica E., et al.
Publicado: (2018)

Late fetal hematopoietic failure results from ZBTB11 deficiency despite abundant HSC specification
por: Cao, Huimin, et al.
Publicado: (2023)

Role and Timing of Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
por: Field, Teresa, et al.
Publicado: (2010)

Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Chen, Yi-Bin, et al.
Publicado: (2009)

Long-Term Engraftment of ESC-Derived B-1 Progenitor Cells Supports HSC-Independent Lymphopoiesis
por: Lin, Yang, et al.
Publicado: (2019)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
por: Scharenberg, Christian, et al.
Publicado: (2017)

Mammalian Granulocyte–Macrophage Colony-stimulating Factor Receptor Expressed in Primary Avian Hematopoietic Progenitors: Lineage-specific Regulation of Proliferation and Differentiation
por: Wessely, Oliver, et al.
Publicado: (1998)

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes
por: Liapis, Konstantinos, et al.
Publicado: (2021)

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
por: Jin, Xin, et al.
Publicado: (2018)

TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes
por: Iriani, Anggraini, et al.
Publicado: (2023)

MORPHOLOGIC CHANGES OF NEUTROPHILS IN MYELODYSPLASTIC SYNDROME TREATED WITH RECOMBINANT HUMAN GRANULOCYTE COLONY‐STIMULATING FACTOR
por: Toyama, Keisuke, et al.
Publicado: (1988)

Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor
por: Ohyashiki, Kazuma, et al.
Publicado: (1989)

Hsc70’s trip to the tip
por: Leslie, Mitch
Publicado: (2015)

Thrombopoietin: tickling the HSC's fancy
por: Kim, Ah Ram, et al.
Publicado: (2017)

Structure of clathrin coat with bound Hsc70 and auxilin: mechanism of Hsc70-facilitated disassembly
por: Xing, Yi, et al.
Publicado: (2010)

Awakening the HSC: Dynamic Modeling of HSC Maintenance Unravels Regulation of the TP53 Pathway and Quiescence
por: Ikonomi, Nensi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_igm0e89j4ejcg1pf4ukals921b